Abacavir does not influence the rate of sustained virological response in HIV-HCV co-infected patients treated with pegylated interferon and weight adjusted ribavirin

INTRODUCTION: Combination of pegylated-interferon (PEG-IFN) plus ribavirin (RBV) is the standard-of-care for hepatitis C virus (HCV) treatment in HIV coinfected individuals. In 2007, abacavir (ABC)-based antiretroviral therapy was for the first time reported to be associated with early virological f...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: N, Laufer, M, Laguno, I, Perez, C, Cifuentes, J, Murillas, F, Vidal, L, Bonet, S, Veloso, JM, Gatell, J, Mallolas
格式: Artigo
語言:Inglês
出版: 2008
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2883773/
https://ncbi.nlm.nih.gov/pubmed/19043930
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍